Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120926 · ClinicalTrials.gov registry record · Phase 3
Dose Comparison of Amino Acids on Growth in Premature Neonates
A Phase 3 study of Malnutrition, sponsored by Pediatrix.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00120926 is a Phase 3 study of Malnutrition that has completed, run by Pediatrix. The registered enrollment target is 150 participants, below the 380-participant average among 17 other Malnutrition trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00120926, a Phase 3 study of Malnutrition, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Malnutrition is a common problem in the neonatal intensive care unit. Recent studies indicate that prematurely born neonates commonly develop a severe nutritional deficit during the first weeks after birth, referred to as extrauterine growth restriction. Despite an increase in growth during the second month of hospitalization, many neonates are ultimately discharged home having grown inadequately. The early nutritional deficit affects weight gain as well as growth in length and head circumference. Growth measurements such as weight, length, and head circumference, however, are macroscopic measures of nutritional status and underestimate the physiologic consequences of prolonged nutritional deprivation. Energy and micronutrient deficiencies alter growth at a cellular and tissue level before macroscopic measures are altered. In the brain, for instance, energy is required for cell division and neuronal growth, glial cell function, and myelination. Energy deprivation may consequently alter neuronal function and growth, resulting in adverse neurodevelopmental outcomes. Immunocompetence also appears to be sensitive to the untoward effects of energy and nutritional deficiency. Malnourished neonates often exhibit immune deficiencies related to inadequate protein intake that compound an already immature immune system. Such immunodeficiency results in susceptibility to infectious agents that creates substantial morbidity and mortality to the course of intensive care for premature infants. A recent study suggests that postnatal malnutrition and growth restriction are inevitable if current recommended dietary intakes are followed. Multicenter studies show that variation in dietary intake accounts for 45% of the variation in growth. Hence, efforts have focused on determining whether nutritional deficiency and the observed growth restriction of premature infants can be prevented through the use of more optimal nutritional intake. In addition, inadequate protein support may be
Conditions Studied
Interventions
- DRUG Parenteral Nutrition
Study Locations (1)
South Carolina
- McLeod Regional Medical Center - Florence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120926
The ClinicalTrials.gov registry entry for NCT00120926 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 17 other Malnutrition trials with a reported enrollment target (61% lower). The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malnutrition appearing as the primary indexed condition, and to 1 intervention - of which Parenteral Nutrition is the first listed.
NCT00120926 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00120926 about?
NCT00120926 is a clinical study titled "Dose Comparison of Amino Acids on Growth in Premature Neonates". Malnutrition is a common problem in the neonatal intensive care unit. Recent studies indicate that prematurely born neonates commonly develop a severe nutritional deficit during the first weeks after birth, referred to as extrauterine growth restriction. Despite an increase in growth during the seco...
What is the current status of trial NCT00120926?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2005-08. Estimated completion is 2006-06.
What conditions does trial NCT00120926 study?
This clinical trial studies the following conditions: Malnutrition.
What interventions are being tested in trial NCT00120926?
The interventions under investigation include: Parenteral Nutrition (DRUG).
Who is sponsoring clinical trial NCT00120926?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00120926 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malnutrition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RCT: Early Feeding After PEG Placement
RECRUITING · NA
-
Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)
RECRUITING · NA
-
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RECRUITING
-
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
RECRUITING · Phase 4
-
Breath Analysis & Malnutrition
RECRUITING · NA
-
Nutrition in Patient With Critical Limb Ischemia
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.